Back | Next |
home / stock / ogen / ogen message board
Subject | By | Source | When |
---|---|---|---|
Qiagen has received emergency use authorization from the | retired early | investorshub | 08/06/2021 5:28:47 PM |
$OGEN will be a player....opportunity knocks. | oakrock | investorshub | 07/28/2021 10:37:21 PM |
Been a nice atm. | GREGG THE GREEK | investorshub | 07/28/2021 1:16:12 PM |
What will happen today? Morning dip into low | Lowhndcpr | investorshub | 07/28/2021 1:02:49 PM |
Here comes eod volume | MADDSTACKER | investorshub | 07/27/2021 6:43:39 PM |
$100-$200M from Canadian govt funding ? | shurtha2000 | investorshub | 07/27/2021 3:07:23 PM |
Should thin out soon | MADDSTACKER | investorshub | 07/27/2021 2:57:35 PM |
EPIC :) | retired early | investorshub | 07/27/2021 1:36:20 PM |
Could be epic | MADDSTACKER | investorshub | 07/27/2021 12:46:59 PM |
Big day looming here after $OGEN announcement of | bigbut | investorshub | 07/27/2021 12:19:57 PM |
Nice day here. Need to get back to | Lowhndcpr | investorshub | 07/19/2021 8:05:10 PM |
O-0 | 420man | investorshub | 06/07/2021 10:48:12 PM |
$OGEN cover time :-) | dancy | investorshub | 05/18/2021 6:32:53 PM |
* * $OGEN Video Chart 04-23-2021 * * | ClayTrader | investorshub | 04/23/2021 10:38:01 PM |
It's all about the therapeutics, peutics, peutics. :) | retired early | investorshub | 04/23/2021 4:14:33 PM |
It's time for the CEO to get his | trendzone | investorshub | 04/09/2021 5:45:39 PM |
Past time.................But I can wait. | DMOST | investorshub | 04/09/2021 8:07:38 AM |
Time to.move up | oxnous | investorshub | 04/09/2021 1:24:03 AM |
Sorry, spike.... | Golden Cross | investorshub | 04/07/2021 12:53:20 AM |
$OGEN Meandering up from the morning low on | geocam | investorshub | 03/30/2021 8:40:46 PM |
News, Short Squeeze, Breakout and More Instantly...
SARASOTA, Fla., June 27, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced it has completed a prototype of its automated intranasal device for use in concu...
SARASOTA, Fla., June 26, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced the closing of its public offering of 1,100,000 shares of its common stock ...